$640 Million is the total value of Soleus Capital Management, L.P.'s 74 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $69,641,000 | +26.9% | 295,541 | -3.4% | 10.86% | +53.5% |
| SKIN | Buy | THE BEAUTY HEALTH COMPANY | $42,130,000 | +996.6% | 3,276,037 | +1339.3% | 6.57% | +1225.0% |
| ORGO | Buy | ORGANOGENESIS HLDGS INC | $25,796,000 | +33.3% | 5,286,167 | +108.1% | 4.02% | +61.2% |
| SRDX | Buy | SURMODICS INC | $24,609,000 | -2.8% | 661,004 | +18.4% | 3.84% | +17.5% |
| EDAP | Buy | EDAP TMS S Asponsored adr | $22,332,000 | -2.2% | 3,284,189 | +4.3% | 3.48% | +18.3% |
| IRMD | Buy | IRADIMED CORP | $21,069,000 | +9.3% | 620,765 | +44.3% | 3.29% | +32.1% |
| CVS | Buy | CVS HEALTH CORP | $20,330,000 | +117.2% | 219,400 | +137.2% | 3.17% | +162.5% |
| THTX | Buy | THERATECHNOLOGIES INC | $17,757,000 | -5.8% | 7,822,412 | +1.7% | 2.77% | +13.9% |
| SKIN | New | THE BEAUTY HEALTH COMPANYcall | $16,718,000 | – | 1,300,000 | +100.0% | 2.61% | – |
| Sell | ARCELLX INC | $16,448,000 | +18.5% | 909,739 | -8.1% | 2.57% | +43.4% | |
| INSP | Buy | INSPIRE MED SYS INC | $16,248,000 | +32.2% | 88,950 | +85.7% | 2.54% | +59.8% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $14,083,000 | -26.8% | 214,482 | -25.9% | 2.20% | -11.6% |
| EPIX | Sell | ESSA PHARMA INC | $13,132,000 | -49.7% | 4,168,799 | -1.3% | 2.05% | -39.2% |
| ANAB | New | ANAPTYSBIO INC | $13,065,000 | – | 643,575 | +100.0% | 2.04% | – |
| ANGO | Sell | ANGIODYNAMICS INC | $12,965,000 | -41.4% | 670,000 | -34.7% | 2.02% | -29.1% |
| Sell | DICE THERAPEUTICS INC | $12,660,000 | -32.7% | 815,740 | -17.1% | 1.98% | -18.7% | |
| NRIX | Sell | NURIX THERAPEUTICS INC | $12,600,000 | -11.1% | 994,492 | -1.7% | 1.97% | +7.5% |
| APEN | Buy | APOLLO ENDOSURGERY INC | $11,932,000 | -31.8% | 3,268,948 | +13.0% | 1.86% | -17.6% |
| NPCE | Buy | NEUROPACE INC | $11,553,000 | -39.4% | 2,334,003 | +0.4% | 1.80% | -26.8% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $11,212,000 | +50.0% | 169,696 | +50.6% | 1.75% | +81.4% |
| TNDM | New | TANDEM DIABETES CARE INC | $10,879,000 | – | 183,800 | +100.0% | 1.70% | – |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $9,731,000 | +484.8% | 841,018 | +834.5% | 1.52% | +606.0% |
| CUTR | New | CUTERA INC | $9,660,000 | – | 257,600 | +100.0% | 1.51% | – |
| EOLS | Sell | EVOLUS INC | $9,404,000 | -38.7% | 810,676 | -40.8% | 1.47% | -25.9% |
| BCAB | Buy | BIOATLA INC | $9,299,000 | -26.1% | 3,262,703 | +29.7% | 1.45% | -10.6% |
| ISEE | Sell | IVERIC BIO INC | $8,796,000 | -45.8% | 914,346 | -5.2% | 1.37% | -34.5% |
| PEN | New | PENUMBRA INC | $8,567,000 | – | 68,800 | +100.0% | 1.34% | – |
| PCVX | Buy | VAXCYTE INC | $8,065,000 | +1.7% | 370,650 | +12.9% | 1.26% | +23.0% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $7,944,000 | – | 719,600 | +100.0% | 1.24% | – |
| PIRS | PIERIS PHARMACEUTICALS INC | $7,732,000 | -38.3% | 4,134,868 | 0.0% | 1.21% | -25.4% | |
| STE | Sell | STERIS PLC | $7,691,000 | -22.9% | 37,310 | -9.6% | 1.20% | -6.8% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $7,464,000 | -8.0% | 258,100 | +2.8% | 1.16% | +11.2% |
| CVRX | Buy | CVRX INC | $6,365,000 | +10.4% | 1,059,040 | +10.1% | 0.99% | +33.6% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $6,209,000 | – | 77,842 | +100.0% | 0.97% | – |
| INCY | New | INCYTE CORP | $6,055,000 | – | 79,700 | +100.0% | 0.94% | – |
| TMDX | New | TRANSMEDICS GROUP INC | $5,801,000 | – | 184,455 | +100.0% | 0.90% | – |
| STAA | New | STAAR SURGICAL CO | $5,326,000 | – | 75,094 | +100.0% | 0.83% | – |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $5,330,000 | -18.0% | 846,000 | +8.0% | 0.83% | -0.8% |
| NARI | New | INARI MED INC | $4,916,000 | – | 72,298 | +100.0% | 0.77% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $4,817,000 | -39.7% | 194,400 | -5.6% | 0.75% | -27.1% |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $4,727,000 | -67.2% | 100,000 | -50.6% | 0.74% | -60.4% |
| EXAS | New | EXACT SCIENCES CORP | $4,687,000 | – | 119,000 | +100.0% | 0.73% | – |
| NTRA | Sell | NATERA INC | $4,674,000 | -25.9% | 131,873 | -14.9% | 0.73% | -10.3% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $4,377,000 | – | 318,100 | +100.0% | 0.68% | – |
| ESTA | New | ESTABLISHMENT LABS HLDGS INC | $4,263,000 | – | 78,400 | +100.0% | 0.66% | – |
| INMD | Buy | INMODE LTD | $4,201,000 | -22.3% | 187,449 | +28.0% | 0.66% | -6.2% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $3,925,000 | +133.4% | 490,000 | +104.2% | 0.61% | +182.0% |
| CCXI | New | CHEMOCENTRYX INC | $3,826,000 | – | 154,400 | +100.0% | 0.60% | – |
| CELC | Buy | CELCUITY INC | $3,812,000 | +1170.7% | 418,912 | +1206.1% | 0.60% | +1425.6% |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $3,815,000 | -49.6% | 196,018 | -42.9% | 0.60% | -39.0% |
| LNTH | Sell | LANTHEUS HLDGS INC | $3,646,000 | -63.1% | 55,222 | -69.1% | 0.57% | -55.3% |
| DXCM | Buy | DEXCOM INC | $3,520,000 | -40.7% | 47,236 | +306.9% | 0.55% | -28.3% |
| LYRA | New | LYRA THERAPEUTICS INC | $3,347,000 | – | 592,417 | +100.0% | 0.52% | – |
| FGEN | Sell | FIBROGEN INC | $3,192,000 | -75.1% | 302,226 | -71.6% | 0.50% | -69.8% |
| Sell | IO BIOTECH INC | $3,061,000 | -14.1% | 655,404 | -2.6% | 0.48% | +3.9% | |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $2,932,000 | – | 20,100 | +100.0% | 0.46% | – |
| XENE | Sell | XENON PHARMACEUTICALS INC | $2,282,000 | -60.7% | 75,000 | -60.5% | 0.36% | -52.5% |
| CCCC | Buy | C4 THERAPEUTICS INC | $2,131,000 | -47.3% | 282,640 | +69.5% | 0.33% | -36.4% |
| KZR | New | KEZAR LIFE SCIENCES INC | $2,084,000 | – | 252,000 | +100.0% | 0.32% | – |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $2,060,000 | -27.4% | 136,182 | -43.0% | 0.32% | -12.3% |
| VSTM | VERASTEM INC | $1,908,000 | -17.7% | 1,644,500 | 0.0% | 0.30% | -0.3% | |
| New | PEPGEN INC | $1,738,000 | – | 175,000 | +100.0% | 0.27% | – | |
| KDNY | New | CHINOOK THERAPEUTICS INC | $1,539,000 | – | 88,000 | +100.0% | 0.24% | – |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $1,337,000 | -3.2% | 22,000 | 0.0% | 0.21% | +17.4% | |
| Sell | XILIO THERAPEUTICS INC | $1,325,000 | -60.8% | 453,660 | -5.0% | 0.21% | -52.5% | |
| CGEM | New | CULLINAN ONCOLOGY INC | $1,224,000 | – | 95,485 | +100.0% | 0.19% | – |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $1,068,000 | -8.7% | 1,950,000 | 0.0% | 0.17% | +10.6% | ||
| OM | New | OUTSET MED INC | $1,028,000 | – | 69,200 | +100.0% | 0.16% | – |
| NVCR | Sell | NOVOCURE LTD | $923,000 | -35.5% | 13,275 | -23.2% | 0.14% | -22.2% |
| IMUX | IMMUNIC INC | $833,000 | -69.3% | 240,000 | 0.0% | 0.13% | -62.9% | |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $726,000 | – | 825,000 | +100.0% | 0.11% | – |
| Sell | DA32 LIFE SCNCE TEC ACQSTN C | $485,000 | -50.1% | 50,000 | -50.0% | 0.08% | -39.2% | |
| OLK | Exit | OLINK HLDG ABsponsored ads | $0 | – | -53,961 | -100.0% | -0.12% | – |
| PCRX | Exit | PACIRA BIOSCIENCES INC | $0 | – | -22,250 | -100.0% | -0.22% | – |
| Exit | CYTEK BIOSCIENCES INC | $0 | – | -180,000 | -100.0% | -0.25% | – | |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -159,200 | -100.0% | -0.25% | – |
| LQDA | Exit | LIQUIDIA CORPORATION | $0 | – | -293,485 | -100.0% | -0.27% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -69,000 | -100.0% | -0.30% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -7,800 | -100.0% | -0.30% | – |
| ARYD | Exit | ARYA SCIENCES ACQU CORP IVcl a | $0 | – | -300,000 | -100.0% | -0.38% | – |
| SIEN | Exit | SIENTRA INC | $0 | – | -1,641,337 | -100.0% | -0.47% | – |
| NEO | Exit | NEOGENOMICS INC | $0 | – | -460,000 | -100.0% | -0.72% | – |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -106,139 | -100.0% | -1.04% | – |
| SNN | Exit | SMITH & NEPHEW PLCspdn adr new | $0 | – | -385,000 | -100.0% | -1.58% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -225,600 | -100.0% | -2.24% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -3,055,193 | -100.0% | -2.67% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -62,300 | -100.0% | -2.81% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -1,408,100 | -100.0% | -16.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.